Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Investigating hypoxic tumor physiology through gene expression patterns

Abstract

Clinical evidence shows that tumor hypoxia is an independent prognostic indicator of poor patient outcome. Hypoxic tumors have altered physiologic processes, including increased regions of angiogenesis, increased local invasion, increased distant metastasis and altered apoptotic programs. Since hypoxia is a potent controller of gene expression, identifying hypoxia-regulated genes is a means to investigate the molecular response to hypoxic stress. Traditional experimental approaches have identified physiologic changes in hypoxic cells. Recent studies have identified hypoxia-responsive genes that may define the mechanism(s) underlying these physiologic changes. For example, the regulation of glycolytic genes by hypoxia can explain some characteristics of the Warburg effect. The converse of this logic is also true. By identifying new classes of hypoxia-regulated gene(s), we can infer the physiologic pressures that require the induction of these genes and their protein products. Furthermore, these physiologically driven hypoxic gene expression changes give us insight as to the poor outcome of patients with hypoxic tumors. Approximately 1–1.5% of the genome is transcriptionally responsive to hypoxia. However, there is significant heterogeneity in the transcriptional response to hypoxia between different cell types. Moreover, the coordinated change in the expression of families of genes supports the model of physiologic pressure leading to expression changes. Understanding the evolutionary pressure to develop a ‘hypoxic response’ provides a framework to investigate the biology of the hypoxic tumor microenvironment.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Becerra M, Lombardia-Ferreira LJ, Hauser NC, Hoheisel JD, Tizon B and Cerdan ME . (2002). Mol. Microbiol., 43, 545–555.

  • Bhattacharya S, Michels CL, Leung MK, Arany ZP, Kung AL and Livingston DM . (1999). Genes Dev., 13, 64–75.

  • Brizel DM, Scully SP, Harrelson JM, Layfield LJ, Bean JM, Prosnitz LR and Dewhirst MW . (1996). Cancer Res., 56, 941–943.

  • Bruick RK . (2000). Proc. Natl. Acad. Sci. USA, 97, 9082–9087.

  • Bruick RK and McKnight SL . (2001). Science, 11, 11.

  • Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W and Nagy A . (1996). Nature, 380, 435–439.

  • Caro J . (2001). High Alt. Med. Biol., 2, 145–154.

  • Chan DA, Sutphin PD, Denko NC and Giaccia AJ . (2002). J. Biol. Chem., 277, 40112–40117.

  • Chen EY, Fujinaga M and Giaccia AJ . (1999a). Teratology, 60, 215–225.

  • Chen G, Cizeau J, Vande Velde C, Park JH, Bozek G, Bolton J, Shi L, Dubik D and Greenberg A . (1999b). J. Biol. Chem., 274, 7–10.

  • De Jaeger K, Kavanagh MC and Hill RP . (2001). Br. J. Cancer, 84, 1280–1285.

  • Denko N, Schindler C, Koong A, Laderoute K, Green C and Giaccia A . (2000a). Clin. Cancer Res., 6, 480–487.

  • Denko N, Wernke-Dollries K, Johnson AB, Hammond E, Chiang CM and Barton MC . (2003). J. Biol. Chem., 278, 5744–5749.

  • Denko NC and Giaccia AJ . (2001). Cancer Res., 61, 795–798.

  • Denko NC, Green SL, Edwards D and Giaccia AJ . (2000b). Exp. Cell Res., 258, 82–91.

  • Dvorak HF . (1986). N. Engl. J. Med., 315, 1650–1659.

  • Ebert BL, Firth JD and Ratcliffe PJ . (1995). J. Biol. Chem., 270, 29083–29089.

  • Ebert BL, Gleadle JM, O'Rourke JF, Bartlett SM, Poulton J and Ratcliffe PJ . (1996). Biochem. J., 313 (Part 3), 809–814.

  • Elson DA, Ryan HE, Snow JW, Johnson R and Arbeit JM . (2000). Cancer Res., 60, 6189–6195.

  • Enholm B, Paavonen K, Ristimaki A, Kumar V, Gunji Y, Klefstrom J, Kivinen L, Laiho M, Olofsson B, Joukov V, Eriksson U and Alitalo K . (1997). Oncogene, 14, 2475–2483.

  • Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ and Ratcliffe PJ. . (2001). Cell, 107, 43–54.

  • Faller DV . (1999). Clin. Exp. Pharmacol. Physiol., 26, 74–84.

  • Fandrey J and Bunn HF . (1993). Blood, 81, 617–623.

  • Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ and Moore MW . (1996). Nature, 380, 439–442.

  • Friedrich CA . (1999). Cancer, 86, 2478–2482.

  • Gleadle JM, Ebert BL, Firth JD and Ratcliffe PJ . (1995). Am. J. Physiol., 268, C1362–C1368.

  • Goldberg MA, Dunning SP and Bunn HF . (1988). Science, 242, 1412–1415.

  • Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW and Giaccia AJ . (1996). Nature, 379, 88–91.

  • Graham CH, Fitzpatrick TE and McCrae KR . (1998). Blood, 91, 3300–3307.

  • Green J, Scott C and Guest JR . (2001). Adv. Microb. Physiol., 44, 1–34.

  • Grunstein J, Roberts WG, Mathieu-Costello O, Hanahan D and Johnson RS . (1999). Cancer Res., 59, 1592–1598.

  • Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U and Vaupel P . (1996). Cancer Res., 56, 4509–4515.

  • Hockel M and Vaupel P . (2001). J. Natl. Cancer Inst., 93, 266–276.

  • Hon WC, Wilson MI, Harlos K, Claridge TD, Schofield CJ, Pugh CW, Maxwell PH, Ratcliffe PJ, Stuart DI and Jones EY . (2002). Nature, 417, 975–978.

  • Imagawa S, Goldberg MA, Doweiko J and Bunn HF . (1991). Blood, 77, 278–285.

  • Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS and Kaelin Jr WG . (2001). Science, 292, 464–468.

  • Ivanov S, Liao SY, Ivanova A, Danilkovitch-Miagkova A, Tarasova N, Weirich G, Merrill MJ, Proescholdt MA, Oldfield EH, Lee J, Zavada J, Waheed A, Sly W, Lerman MI and Stanbridge EJ . (2001). Am. J. Pathol., 158, 905–919.

  • Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH, Gassmann M, Gearhart JD, Lawler AM, Yu AY and Semenza GL . (1998). Genes Dev., 12, 149–162.

  • Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW and Ratcliffe PJ . (2001). Science, 292, 468–472.

  • Jiang BH, Rue E, Wang GL, Roe R and Semenza GL . (1996). J. Biol. Chem., 271, 17771–17778.

  • Kamada K, Shu F, Chen H, Malik S, Stelzer G, Roeder RG, Meisterernst M and Burley SK . (2001). Cell, 106, 71–81.

  • Kondo K, Klco J, Nakamura E, Lechpammer M and Kaelin Jr WG . (2002). Cancer Cell, 1, 237–246.

  • Koong AC, Denko NC, Hudson KM, Schindler C, Swiersz L, Koch C, Evans S, Ibrahim H, Le QT, Terris DJ and Giaccia AJ . (2000). Cancer Res., 60, 883–887.

  • Koumenis C, Alarcon R, Hammond E, Sutphin P, Hoffman W, Murphy M, Derr J, Taya Y, Lowe SW, Kastan M and Giaccia A . (2001). Mol. Cell Biol., 21, 1297–1310.

  • Kourembanas S, McQuillan LP, Leung GK and Faller DV . (1993). J. Clin. Invest., 92, 99–104.

  • Laderoute KR, Alarcon RM, Brody MD, Calaoagan JM, Chen EY, Knapp AM, Yun Z, Denko NC and Giaccia AJ . (2000). Clin. Cancer Res., 6, 2941–2950.

  • Mandriota SJ and Pepper MS . (1998). Circ. Res., 83, 852–859.

  • Maxwell PH, Dachs GU, Gleadle JM, Nicholls LG, Harris AL, Stratford IJ, Hankinson O, Pugh CW and Ratcliffe PJ . (1997). Proc. Natl. Acad. Sci. USA, 94, 8104–8109.

  • Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER and Ratcliffe PJ . (1999). Nature, 399, 271–275.

  • Melillo G, Musso T, Sica A, Taylor LS, Cox GW and Varesio L . (1995). J. Exp. Med., 182, 1683–1693.

  • Millhorn DE, Conforti L, Beitner-Johnson D, Zhu W, Raymond R, Filisko T, Kobayashi S, Peng M and Genter MB . (1996). Adv. Exp. Med. Biol., 410, 135–142.

  • Min JH, Yang H, Ivan M, Gertler F, Kaelin Jr WG and Pavletich NP . (2002). Science, 296, 1886–1889.

  • Nakayama M, Takahashi K, Murakami O, Shirato K and Shibahara S . (1998). Biochem. Biophys. Res. Commun., 243, 514–517.

  • Niitsu Y, Hori O, Yamaguchi A, Bando Y, Ozawa K, Tamatani M, Ogawa S and Tohyama M . (1999). Brain. Res. Mol. Brain Res., 74, 26–34.

  • Nordsmark M, Overgaard M and Overgaard J . (1996). Radiother. Oncol., 41, 31–39.

  • Oikawa M, Abe M, Kurosawa H, Hida W, Shirato K and Sato Y . (2001). Biochem. Biophys. Res. Commun., 289, 39–43.

  • Oosthuyse B, Moons L, Storkebaum E, Beck H, Nuyens D, Brusselmans K, Van Dorpe J, Hellings P, Gorselink M, Heymans S, Theilmeier G, Dewerchin M, Laudenbach V, Vermylen P, Raat H, Acker T, Vleminckx V, Van Den Bosch L, Cashman N, Fujisawa H, Drost MR, Sciot R, Bruyninckx F, Hicklin DJ, Ince C, Gressens P, Lupu F, Plate KH, Robberecht W, Herbert JM, Collen D and Carmeliet P . (2001). Nat. Genet., 28, 131–138.

  • O'Rourke JF, Pugh CW, Bartlett SM and Ratcliffe PJ . (1996). Eur. J. Biochem., 241, 403–410.

  • Ozawa K, Tsukamoto Y, Hori O, Kitao Y, Yanagi H, Stern DM and Ogawa S . (2001). Cancer Res., 61, 4206–4213.

  • Pinsky DJ, Liao H, Lawson CA, Yan SF, Chen J, Carmeliet P, Loskutoff DJ and Stern DM . (1998). J. Clin. Invest., 102, 919–928.

  • Plate KH, Breier G, Millauer B, Ullrich A and Risau W . (1993). Cancer. Res., 53, 5822–5827.

  • Postovit LM, Adams MA, Lash GE, Heaton JP and Graham CH . (2002). J. Biol. Chem., 277, 35730–35737.

  • Raychaudhuri S, Stuart JM and Altman RB . (2000). Pac. Symp. Biocomput., 455–466.

  • Roll DE, Murphy BJ, Laderoute KR, Sutherland RM and Smith HC . (1991). Mol. Cell Biochem., 103, 141–148.

  • Ryan HE, Lo J and Johnson RS . (1998). EMBO. J., 17, 3005–3015.

  • Saarikoski ST, Rivera SP and Hankinson O . (2002). FEBS Lett., 530, 186–190.

  • Salceda S, Beck I and Caro J . (1996). Arch. Biochem. Biophys., 334, 389–394.

  • Scandurro AB, Weldon CW, Figueroa YG, Alam J and Beckman BS . (2001). Int. J. Oncol., 19, 129–135.

  • Schmedtje Jr JF, Ji YS, Liu WL, DuBois RN and Runge MS . (1997). J. Biol. Chem., 272, 601–608.

  • Seagroves TN, Ryan HE, Lu H, Wouters BG, Knapp M, Thibault P, Laderoute K and Johnson RS . (2001). Mol. Cell. Biol., 21, 3436–3444.

  • Semenza GL, Roth PH, Fang HM and Wang GL . (1994). J. Biol. Chem., 269, 23757–23763.

  • Shweiki D, Itin A, Soffer D and Keshet E . (1992). Nature, 359, 843–845.

  • Sowter HM, Ratcliffe PJ, Watson P, Greenberg AH and Harris AL . (2001). Cancer Res., 61, 6669–6673.

  • Suzuma K, Takagi H, Otani A and Honda Y . (1998). Invest. Ophthalmol. Vis. Sci., 39, 1028–1035.

  • Tazuke SI, Mazure NM, Sugawara J, Carland G, Faessen GH, Suen LF, Irwin JC, Powell DR, Giaccia AJ and Giudice LC . (1998). Proc. Natl. Acad. Sci. USA, 95, 10188–10193.

  • Teicher BA . (1994). Cancer Metast. Rev., 13, 139–168.

  • Ten VS and Pinsky DJ . (2002). Curr. Opin. Crit. Care, 8, 242–250.

  • Tenan M, Fulci G, Albertoni M, Diserens AC, Hamou MF, El Atifi-Borel M, Feige JJ, Pepper MS and Van Meir EG . (2000). J. Exp. Med., 191, 1789–1798.

  • Wang C, Valtavaara M and Myllyla R . (2000). DNA Cell Biol., 19, 71–77.

  • Wang GL and Semenza GL . (1993). Proc. Natl. Acad. Sci USA, 90, 4304–4308.

  • Warren SM, Steinbrech DS, Mehrara BJ, Saadeh PB, Greenwald JA, Spector JA, Bouletreau PJ and Longaker MT . (2001). J. Surg. Res., 99, 147–155.

  • Wykoff CC, Pugh CW, Maxwell PH, Harris AL and Ratcliffe PJ . (2000). Oncogene, 19, 6297–6305.

  • Yan SF, Lu J, Zou YS, Soh-Won J, Cohen DM, Buttrick PM, Cooper DR, Steinberg SF, Mackman N, Pinsky DJ and Stern DM . (1999). J. Biol. Chem., 274, 15030–15040.

  • Yan SF, Zou YS, Gao Y, Zhai C, Mackman N, Lee SL, Milbrandt J, Pinsky D, Kisiel W and Stern D . (1998). Proc. Natl. Acad. Sci. USA, 95, 8298–8303.

  • Yun Z, Maecker HL, Johnson RS and Giaccia AJ . (2002). Dev. Cell, 2, 331–341.

  • Zitomer RS, Carrico P and Deckert J . (1997). Kidney Int., 51, 507–513.

Download references

Acknowledgements

This work was supported in part by Varian Biosynergy and NIH Grant CA67166. LF was supported by a predoctoral fellowship from Fondazione Italiana per la Ricerca sul Cancero.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nicholas C Denko.

Additional information

Supplemental data is available at: http://cbrl.stanford.edu/hypoxia/welcome.htm

Rights and permissions

Reprints and permissions

About this article

Cite this article

Denko, N., Fontana, L., Hudson, K. et al. Investigating hypoxic tumor physiology through gene expression patterns. Oncogene 22, 5907–5914 (2003). https://doi.org/10.1038/sj.onc.1206703

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206703

Keywords

This article is cited by

Search

Quick links